Lars Rogge
Impact in
- Immunology top 0.5%
- T-cell and B-cell Immunology
- IL-33, ST2, and ILC Pathways
- interferon and immune responses
- Immune Cell Function and Interaction
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Immunology 52
- T-cell and B-cell Immunology 34
- Psoriasis: Treatment and Pathogenesis 8
- interferon and immune responses 6
- Immune Response and Inflammation 5
- Rheumatology 13
- Spondyloarthritis Studies and Treatments 11
- Co-authors
- Francesco Sinigaglia (17 shared papers)Elisabetta Bianchi (26 shared papers)Mauro Biffi (7 shared papers)David H. Presky (5 shared papers)Nadia Passini (7 shared papers)Luisella Barberis-Maino (2 shared papers)Ueli Gubler (2 shared papers)Daniele D’Ambrosio (5 shared papers)
In The Last Decade
Lars Rogge
91 papers receiving 8.2k citations
Lars Rogge's Hit Papers
Peers
Comparison fields: 5 of 124
- Immunology 3.4k
- Infectious Diseases 1.5k
- Rheumatology 456
- Immunology and Allergy 165
- Oncology 686
Countries citing papers authored by Lars Rogge
This map shows the geographic impact of Lars Rogge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Rogge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Rogge more than expected).
Fields of papers citing papers by Lars Rogge
This network shows the impact of papers produced by Lars Rogge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Rogge. The network helps show where Lars Rogge may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Rogge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Autoantibodies against type I IFNs in patients with life-threatening COVID-19 Hit paper breakdown → | 2020 | 2107 |
| 2 | 1997 | 685 | |
| 3 | 2017 | 434 | |
| 4 | 2006 | 387 | |
| 5 | 1998 | 257 | |
| 6 | 2016 | 257 | |
| 7 | 2018 | 220 | |
| 8 | 2000 | 198 | |
| 9 | 2000 | 188 | |
| 10 | 2014 | 187 | |
| 11 | 2017 | 176 | |
| 12 | 1995 | 150 | |
| 13 | 2022 | 145 | |
| 14 | 1999 | 129 | |
| 15 | Smoking changes adaptive immunity with persistent effects Hit paper breakdown → | 2024 | 123 |
| 16 | 1999 | 121 | |
| 17 | 2019 | 119 | |
| 18 | 1990 | 117 | |
| 19 | 1999 | 107 | |
| 20 | 2018 | 103 |
About Lars Rogge
Lars Rogge is a scholar working on Immunology, Rheumatology, Molecular Biology, Oncology and Genetics, having authored 95 papers that have together received 8.5k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (34 papers), Spondyloarthritis Studies and Treatments (11 papers), Genomics and Chromatin Dynamics (11 papers), Cytokine Signaling Pathways and Interactions (8 papers), Psoriasis: Treatment and Pathogenesis (8 papers), interferon and immune responses (6 papers), Genetic Associations and Epidemiology (6 papers) and Immune Response and Inflammation (5 papers). The work is most often cited by research in Immunology (3.4k citations), Infectious Diseases (1.5k citations), Rheumatology (456 citations), Immunology and Allergy (165 citations) and Oncology (686 citations). Lars Rogge has collaborated with scholars based in France, Italy and Germany. Frequent co-authors include Francesco Sinigaglia, Elisabetta Bianchi, Mauro Biffi, David H. Presky, Nadia Passini, Luisella Barberis-Maino, Ueli Gubler, Daniele D’Ambrosio, James P. Di Santo and Michael Meisterernst. Their work appears in journals such as The Journal of Immunology, Journal of Biological Chemistry, Nature Communications, Clinical Immunology and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.